The importance of early-stage VC funding
In our latest podcast, Chris Walters, JLL’s Head of UK Life Sciences, is joined by Jason Mellad, Co-Founder & CEO of Startcodon. This episode looks at the opportunities for scaling Life Sciences businesses to gain venture capital backing and the opportunities across the UK to bridge the gap between start-ups and value-add investors.
Missed an episode? Catch up here
CEO & Co-Founder, Start Codon
Jason is a scientist entrepreneur passionate about translating innovative technologies into better patient outcomes. As CEO and co-founder of Start Codon, a Cambridge based venture builder, he aims to identify the most disruptive healthcare founders and innovations worldwide, seed fund them and leverage the exceptional resources of the Cambridge cluster to de-risk and drive the success of their start-ups.
Harriet was a Diplomat for over 20 years with the British Foreign Office. She served in 17 countries, in various roles including Deputy Ambassador 3 times, Head of Press and Public Affairs and Head of Commercial Services. Harriet has worked at the heart of the Cambridge business ecosystem since 2003. She was awarded an MBE in 2016 for her services to Healthcare and Life Sciences. Harriet is currently leading Cambridge&, the shop window for innovation/inward investment service for Greater Cambridge and is Chair of Cambridge Ahead and founder of HFA Ltd.
Head of Clusters, Cell & Gene Therapy Catapult
Kasia Averall is Head of Cluster Development at the Cell and Gene Therapy Catapult. She is responsible for shaping and delivering a strategic UK cell and gene therapy manufacturing cluster working with a variety of organisations to de-risk and speed up the establishment of approved cell and gene therapy manufacturing facilities.
Talk to us about life sciences
Find out how smart location, space and facility management decisions can help fuel your scientific breakthroughs.
Jones Lang LaSalle (JLL), together with its subsidiaries and affiliates, is a leading global provider of real estate and investment management services. We take our responsibility to protect the personal information provided to us seriously.
Generally the personal information we collect from you are for the purposes of dealing with your enquiry.
We endeavor to keep your personal information secure with appropriate level of security and keep for as long as we need it for legitimate business or legal reasons. We will then delete it safely and securely. For more information about how JLL processes your personal data, please view our privacy statement.